Target
Alpha-2B adrenergic receptor
Ligand
BDBM50118703
Substrate
n/a
Meas. Tech.
ChEMBL_33506 (CHEMBL857772)
Ki
245±n/a nM
Citation
 Altenbach, RJKhilevich, AKolasa, TRohde, JJBhatia, PAPatel, MVSearle, XBYang, FBunnelle, WHTietje, KBayburt, EKCarroll, WAMeyer, MDHenry, RBuckner, SAKuk, JDaza, AVMilicic, IVCain, JCKang, CHIreland, LMCarr, TLMiller, TRHancock, AANakane, MEsbenshade, TABrune, MEO'Neill, ABGauvin, DMKatwala, SPHolladay, MWBrioni, JDSullivan, JP Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist. J Med Chem 47:3220-35 (2004) [PubMed]  Article 
Target
Name:
Alpha-2B adrenergic receptor
Synonyms:
ADA2B_RAT | Adra2b | Adrenergic receptor alpha | Adrenergic receptor alpha-2 | Alpha-2B adrenergic receptor | Alpha-2B adrenoceptor | Alpha-2B adrenoreceptor | adrenergic Alpha2B
Type:
Enzyme Catalytic Domain
Mol. Mass.:
50379.83
Organism:
NEONATAL RAT
Description:
adrenergic Alpha2B ADRA2B NEONATAL RAT::P19328
Residue:
453
Sequence:
MSGPTMDHQEPYSVQATAAIASAITFLILFTIFGNALVILAVLTSRSLRAPQNLFLVSLAAADILVATLIIPFSLANELLGYWYFWRAWCEVYLALDVLFCTSSIVHLCAISLDRYWAVSRALEYNSKRTPRRIKCIILTVWLIAAVISLPPLIYKGDQRPEPRGLPQCELNQEAWYILASSIGSFFAPCLIMILVYLRIYVIAKRSHCRGLGAKRGSGEGESKKPQPVAGGVPTSAKVPTLVSPLSSVGEANGHPKPPREKEEGETPEDPEARALPPTWSALPRSGQGQKKGTSGATAEEGDEEDEEEVEECEPQTLPASPASVCNPPLQQPQTSRVLATLRGQVLLGKNVGVASGQWWRRRTQLSREKRFTFVLAVVIGVFVVCWFPFFFSYSLGAICPQHCKVPHGLFQFFFWIGYCNSSLNPVIYTVFNQDFRRAFRRILCRPWTQTGW
  
Inhibitor
Name:
BDBM50118703
Synonyms:
CHEMBL109783 | N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydro-naphthalen-1-yl]-methanesulfonamide
Type:
Small organic molecule
Emp. Form.:
C14H19N3O3S
Mol. Mass.:
309.384
SMILES:
CS(=O)(=O)Nc1c(O)ccc2C(CCCc12)C1=NCCN1 |t:18|
Structure:
Search PDB for entries with ligand similarity: